Cytek Biosciences Inc (CTKB) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.002x

Based on the latest financial reports, Cytek Biosciences Inc (CTKB) has a cash flow conversion efficiency ratio of -0.002x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-771.00K) by net assets ($341.74 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cytek Biosciences Inc - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how Cytek Biosciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read CTKB liabilities breakdown for a breakdown of total debt and financial obligations.

Cytek Biosciences Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cytek Biosciences Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Comintel Corporation Berhad
KLSE:7195
0.117x
Tyntek Corp
TW:2426
0.005x
CARE Ratings Limited
NSE:CARERATING
0.029x
Gansu Yatai Industrial Development Co Ltd
SHE:000691
-0.880x
Canadian Tire Corporation Limited
TO:CTC
-0.053x
Nextdoor Holdings Inc
NYSE:KIND
0.007x
Guangdong Songyang Recycle Resources Co Ltd
SHG:603863
-0.018x
SIS LIMITED
NSE:SIS
0.084x

Annual Cash Flow Conversion Efficiency for Cytek Biosciences Inc (2019–2025)

The table below shows the annual cash flow conversion efficiency of Cytek Biosciences Inc from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see CTKB company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $341.74 Million $-4.69 Million -0.014x -121.38%
2024-12-31 $395.74 Million $25.38 Million 0.064x +377.33%
2023-12-31 $393.06 Million $5.28 Million 0.013x +146.75%
2022-12-31 $425.55 Million $-12.23 Million -0.029x -351.65%
2021-12-31 $405.38 Million $4.63 Million 0.011x +101.21%
2020-12-31 $-16.03 Million $15.16 Million -0.946x -386.84%
2019-12-31 $-41.70 Million $-13.75 Million 0.330x --

About Cytek Biosciences Inc

NASDAQ:CTKB USA Medical Devices
Market Cap
$593.90 Million
Market Cap Rank
#12099 Global
#2852 in USA
Share Price
$4.62
Change (1 day)
+1.32%
52-Week Range
$2.42 - $5.88
All Time High
$27.93
About

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies usin… Read more